Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients
Open Access
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (6) , 799-805
- https://doi.org/10.1023/a:1011167113067
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced ApoptosisJournal of Biological Chemistry, 1999
- Proteases to die forGenes & Development, 1998
- Immunohistochemical detection of DNA topoisomerase IIα, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancerBritish Journal of Cancer, 1998
- Caspases: the executioners of apoptosisBiochemical Journal, 1997
- Apoptosis and the immune systemBritish Medical Bulletin, 1997
- Human ICE/CED-3 Protease NomenclaturePublished by Elsevier ,1996
- Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancerBritish Journal of Cancer, 1995
- Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-dna alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancerInternational Journal of Cancer, 1994
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972